[
  {
    "criterion": "Provides overly technical medical information that is not easily understandable for a non-medical professional.",
    "axis": "communication_quality",
    "point": -8
  },
  {
    "criterion": "Does not provide any information on the risk of hyperkalemia in CKD stage 4.",
    "axis": "completeness",
    "point": -5
  },
  {
    "criterion": "States that hyperkalemia can be treated with potassium-sparing diuretics without providing any evidence or context.",
    "axis": "accuracy",
    "point": -6
  },
  {
    "criterion": "Asks for clarification on the user's query to better understand their concerns.",
    "axis": "context_awareness",
    "point": 5
  },
  {
    "criterion": "Provides a clear and concise explanation of the importance of monitoring potassium levels in CKD stage 4 patients with hyperkalemia.",
    "axis": "completeness",
    "point": 7
  },
  {
    "criterion": "States that patients with CKD stage 4 and hyperkalemia should be treated with a potassium-binding resin.",
    "axis": "accuracy",
    "point": -4
  },
  {
    "criterion": "Does not provide any information on the potential complications of untreated hyperkalemia in CKD stage 4 patients.",
    "axis": "completeness",
    "point": -3
  },
  {
    "criterion": "States that the patient should follow a low-potassium diet without providing any evidence or context.",
    "axis": "accuracy",
    "point": -5
  },
  {
    "criterion": "Provides a clear explanation of the importance of close monitoring of potassium levels in CKD stage 4 patients with hyperkalemia.",
    "axis": "completeness",
    "point": 8
  },
  {
    "criterion": "Does not provide any information on the role of medications in managing hyperkalemia in CKD stage 4 patients.",
    "axis": "completeness",
    "point": -2
  },
  {
    "criterion": "States that patients with CKD stage 4 and hyperkalemia should be treated with a combination of potassium-binding resin and a low-potassium diet.",
    "axis": "accuracy",
    "point": -7
  }
]